(Q37608359)

21 August 2017

Treatment of fibromyalgia: a changing of the guard (English)

1 reference

21 August 2017

0 references

Andrew J Holman

1

1 reference

21 August 2017

1 November 2005

1 reference

21 August 2017

1 reference

21 August 2017

1

1 reference

21 August 2017

3

1 reference

21 August 2017

409-420

1 reference

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Musculosketal Symptoms and Non-REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Sympathetic nervous system function in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

The potential of treatment matching for subgroups of patients with chronic pain: lumping versus splitting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Chronic widespread pain and fibromyalgia: what we know, and what we need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Management of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

21 January 2018

Exercise in fibromyalgia

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Electroacupuncture in fibromyalgia: results of a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Connective tissue massage in the treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

The effect of combined therapy (ultrasound and interferential current) on pain and sleep in fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Balneotherapy for fibromyalgia at the Dead Sea.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Systemic drug treatment for chronic musculoskeletal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

An open clinical trial of venlafaxine treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Venlafaxine Treatment of Fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Alpha sleep characteristics in fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Neural circuits mediating stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

Effect of pramipexole in treatment of resistant restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.409

21 January 2018

Identifiers

DOI

10.2217/17455057.1.3.409

1 reference

21 August 2017

1 reference

PubMed ID

19803882